Treatment of respiratory failure in COPD

Stephan Budweiser1, Rudolf A Jörres2, Michael Pfeifer1,31Center for Pneumology, Hospital Donaustauf, Donaustauf, Germany; 2Institute and Outpatient Clinic for Occupational, Social and Environmental Medicine, Ludwig-Maximilians-University, Munich, Germany; 3Department of Internal Medicin...

Full description

Bibliographic Details
Main Authors: Stephan Budweiser, Rudolf A Jörres, Michael Pfeifer
Format: Article
Language:English
Published: Dove Medical Press 2008-12-01
Series:International Journal of COPD
Online Access:http://www.dovepress.com/treatment-of-respiratory-failure-in-copd-a2685
_version_ 1811287234995814400
author Stephan Budweiser
Rudolf A Jörres
Michael Pfeifer
author_facet Stephan Budweiser
Rudolf A Jörres
Michael Pfeifer
author_sort Stephan Budweiser
collection DOAJ
description Stephan Budweiser1, Rudolf A Jörres2, Michael Pfeifer1,31Center for Pneumology, Hospital Donaustauf, Donaustauf, Germany; 2Institute and Outpatient Clinic for Occupational, Social and Environmental Medicine, Ludwig-Maximilians-University, Munich, Germany; 3Department of Internal Medicine II, Division of Respirology, University of Regensburg, Regensburg, GermanyAbstract: Patients with advanced COPD and acute or chronic respiratory failure are at high risk for death. Beyond pharmacological treatment, supplemental oxygen and mechanical ventilation are major treatment options. This review describes the physiological concepts underlying respiratory failure and its therapy, as well as important treatment outcomes. The rationale for the controlled supply of oxygen in acute hypoxic respiratory failure is undisputed. There is also a clear survival benefit from long-term oxygen therapy in patients with chronic hypoxia, while in mild, nocturnal, or exercise-induced hypoxemia such long-term benefits appear questionable. Furthermore, much evidence supports the use of non-invasive positive pressure ventilation in acute hypercapnic respiratory failure. It application reduces intubation and mortality rates, and the duration of intensive care unit or hospital stays, particularly in the presence of mild to moderate respiratory acidosis. COPD with chronic hypercapnic respiratory failure became a major indication for domiciliary mechanical ventilation, based on pathophysiological reasoning and on data regarding symptoms and quality of life. Still, however, its relevance for long-term survival has to be substantiated in prospective controlled studies. Such studies might preferentially recruit patients with repeated hypercapnic decompensation or a high risk for death, while ensuring effective ventilation and the patients’ adherence to therapy.Keywords: respiratory failure, COPD, mechanical ventilation, non-invasive ventilation long-term oxygen therapy, chronic hypercapnic respiratory failure, oxygen
first_indexed 2024-04-13T03:15:08Z
format Article
id doaj.art-45b7c64e631f481fb242dd1c384dcf7d
institution Directory Open Access Journal
issn 1176-9106
1178-2005
language English
last_indexed 2024-04-13T03:15:08Z
publishDate 2008-12-01
publisher Dove Medical Press
record_format Article
series International Journal of COPD
spelling doaj.art-45b7c64e631f481fb242dd1c384dcf7d2022-12-22T03:04:56ZengDove Medical PressInternational Journal of COPD1176-91061178-20052008-12-012008Issue 4605618Treatment of respiratory failure in COPDStephan BudweiserRudolf A JörresMichael PfeiferStephan Budweiser1, Rudolf A Jörres2, Michael Pfeifer1,31Center for Pneumology, Hospital Donaustauf, Donaustauf, Germany; 2Institute and Outpatient Clinic for Occupational, Social and Environmental Medicine, Ludwig-Maximilians-University, Munich, Germany; 3Department of Internal Medicine II, Division of Respirology, University of Regensburg, Regensburg, GermanyAbstract: Patients with advanced COPD and acute or chronic respiratory failure are at high risk for death. Beyond pharmacological treatment, supplemental oxygen and mechanical ventilation are major treatment options. This review describes the physiological concepts underlying respiratory failure and its therapy, as well as important treatment outcomes. The rationale for the controlled supply of oxygen in acute hypoxic respiratory failure is undisputed. There is also a clear survival benefit from long-term oxygen therapy in patients with chronic hypoxia, while in mild, nocturnal, or exercise-induced hypoxemia such long-term benefits appear questionable. Furthermore, much evidence supports the use of non-invasive positive pressure ventilation in acute hypercapnic respiratory failure. It application reduces intubation and mortality rates, and the duration of intensive care unit or hospital stays, particularly in the presence of mild to moderate respiratory acidosis. COPD with chronic hypercapnic respiratory failure became a major indication for domiciliary mechanical ventilation, based on pathophysiological reasoning and on data regarding symptoms and quality of life. Still, however, its relevance for long-term survival has to be substantiated in prospective controlled studies. Such studies might preferentially recruit patients with repeated hypercapnic decompensation or a high risk for death, while ensuring effective ventilation and the patients’ adherence to therapy.Keywords: respiratory failure, COPD, mechanical ventilation, non-invasive ventilation long-term oxygen therapy, chronic hypercapnic respiratory failure, oxygenhttp://www.dovepress.com/treatment-of-respiratory-failure-in-copd-a2685
spellingShingle Stephan Budweiser
Rudolf A Jörres
Michael Pfeifer
Treatment of respiratory failure in COPD
International Journal of COPD
title Treatment of respiratory failure in COPD
title_full Treatment of respiratory failure in COPD
title_fullStr Treatment of respiratory failure in COPD
title_full_unstemmed Treatment of respiratory failure in COPD
title_short Treatment of respiratory failure in COPD
title_sort treatment of respiratory failure in copd
url http://www.dovepress.com/treatment-of-respiratory-failure-in-copd-a2685
work_keys_str_mv AT stephanbudweiser treatmentofrespiratoryfailureincopd
AT rudolfajampoumlrres treatmentofrespiratoryfailureincopd
AT michaelpfeifer treatmentofrespiratoryfailureincopd